Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Enterprise Products Partners LP Unit | EPD | Jan 10, 2025 | 32.17 | -0.83 |
Entrada Therapeutics | TRDA | Jan 10, 2025 | 14.65 | -9.68 |
Entravision Communications | EVC | Jan 10, 2025 | 2.67 | +17.11 |
Envela | ELA | Jan 10, 2025 | 7.08 | -1.26 |
Enveric Biosciences | ENVB | Jan 10, 2025 | 0.40 | -3.34 |
Enviri | NVRI | Jan 10, 2025 | 8.42 | -0.12 |
Environmental Svcs ETF Market Vectors | EVX | Jan 10, 2025 | 172.23 | -0.27 |
Envirotech Vehicles | EVTV | Jan 10, 2025 | 1.15 | -3.36 |
Envista | NVST | Jan 10, 2025 | 18.58 | -3.08 |
Envoy Medical A | COCH | Jan 10, 2025 | 1.47 | -2.00 |
enVVeno Medical | NVNO | Jan 10, 2025 | 3.24 | -3.57 |
Enzo Biochem | ENZ | Jan 10, 2025 | 0.68 | -3.72 |
EOG Resources | EOG | Jan 10, 2025 | 131.41 | +2.30 |
EON Resources A | EONR | Jan 10, 2025 | 0.92 | -14.02 |
Eos Energy Enterprises | EOSE | Jan 10, 2025 | 4.96 | -4.25 |
EPAM Systems | EPAM | Jan 10, 2025 | 225.62 | -1.26 |
EpicQuest Eduaction Group | EEIQ | Jan 10, 2025 | 0.99 | -3.88 |
ePlus | PLUS | Jan 10, 2025 | 76.34 | +0.53 |
EPR Properties | EPR | Jan 10, 2025 | 44.30 | -1.40 |
EPR Properties Pref C | EPR-C | Jan 10, 2025 | 20.55 | -2.24 |
EPR Properties Pref E | EPR-E | Jan 10, 2025 | 27.80 | -0.18 |
EPR Properties Pref G | EPR-G | Jan 10, 2025 | 19.46 | -1.96 |
Epsilon Energy | EPSN | Jan 10, 2025 | 6.36 | 0.00 |
EQT | EQT | Jan 10, 2025 | 49.00 | 0.00 |
Equifax | EFX | Jan 10, 2025 | 244.35 | -1.52 |
Equillium | EQ | Jan 10, 2025 | 0.70 | -2.21 |
Equinix | EQIX | Jan 10, 2025 | 899.83 | -5.38 |
Equinor ADR | EQNR | Jan 10, 2025 | 25.27 | -0.12 |
Equinox Gold | EQX | Jan 10, 2025 | 6.10 | +5.17 |
Equitable A Pref | EQH-A | Jan 10, 2025 | 20.37 | -1.93 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.